Multiple vasospastic manifestations during ergot therapy.
D000328:Adult; D003327:Coronary Disease / Q000139:chemically induced*; D004878:Ergotamine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology*; D013035:Spasm / Q000139:chemically induced
D004878:Ergotamine